Akari Therapeutics (AKTX)

AI Score

Unlock

1.21

0.11 (10.00%)

At close: Apr 17, 2025, 3:33 PM

1.21

0.00%

After-hours: Apr 17, 2025, 04:00 PM EDT

Akari Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Net Income	-2.9M	-7.56M	-5.57M	-3.5K	-3.5K	-3M	1M	-3.45K	-3.45K	-5.68M	-5.18M	-5.79M	-1.45M	-4.35M	-5.84M	-6.82M	1.44M	-8.32M	-3.39M	-7.88M	-2.57M	-4.12M	-2.55M	-3.51M	-3.59M	-8.02M	-1.34M	-12.12M	-10.38M	-320.01K	-12.58M	-8.29M	-418.12K	-6.45M	-2.99M
Depreciation & Amortization	1.00	n/a	13K	1.07	1.07	1.85K	1K	1.03	1.03	942.00	1.01K	1.01K	1.03K	1.05K	1.03K	1K	986.00	3.04K	3.88K	4.31K	4.63K	4.7K	5.57K	7.62K	9.51K	9.38K	9.34K	9.5K	10.34K	11.71K	10.84K	11.48K	9.68K	10.19K	8.59K
Stock-Based Compensation	988.26K	445.00	296.00	304.24	304.24	270.76	265.00	256.65	256.65	122.86K	98.84K	77.05K	70.61K	82.1K	84.89K	80.58K	81.11K	63.33K	100.5K	105.94K	137.38K	409.62K	394.44K	417.34K	403.77K	351.98K	475.96K	505.94K	481.34K	824.55K	923.12K	1.29M	1.02M	805.41K	816.8K
Other Working Capital	-1.6M	564.00	1.6M	534.00	534.00	-499K	-563K	2.2K	2.2K	-2.96M	109.3K	898.21K	-177.73K	-531.65K	-1.93M	827.81	330.46	149.11	-1.12K	345.74	688.71	140.58	-464.7	-245.59	62.62	149.98	-731.88	508.82	-1.01M	-343.7	173.35	2.02M	-172.29K	1.1M	-4.4M
Other Non-Cash Items	2.02M	2.66M	-63K	-763.77	-763.77	-3.06M	-5.32M	-2.96K	-2.96K	-54.14K	-82.36K	49.21K	-1.33K	-70.86K	265.48K	-149.68K	-1.81M	3.29M	-1.48M	-50.24K	-539.47K	-1.91M	2.53M	-1.2M	664K	170.72K	-2.98M	1.19M	1.68M	-6.95M	4.29M	-1.53M	-5.44M	-1.15M	-883.03K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	20.41K	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-1.6M	564.00	1.6M	534.00	534.00	-918.63K	-563K	2.2K	2.2K	-2.96M	109.3K	656.9K	-177.73K	-531.65K	-1.93M	2.66M	-418.56K	683.46K	-2.98M	4.35M	-1.95M	835.63K	-151.14K	-284.53K	-2.82M	-793.66K	-561.32K	1.9M	-1.01M	1.73M	-1.81M	2.02M	-172.29K	1.1M	-4.4M
Operating Cash Flow	-1.49M	-4.89M	-4.04M	-3.43K	-3.43K	-9.57M	-4.88M	-3.94K	-3.94K	-8.57M	-5.05M	-5M	-1.56M	-4.87M	-7.42M	-4.23M	-704.17K	-4.27M	-7.74M	-3.46M	-4.91M	-4.77M	228.94K	-4.57M	-5.33M	-8.28M	-4.4M	-8.52M	-9.21M	-4.7M	-9.17M	-6.49M	-5M	-5.69M	-7.44M
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-31.27K	-5.62K	-6.77K	n/a	-5.9K	-42.08K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-46.12M	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	10.02M	n/a	n/a	n/a	35.08M	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	379.07	-379.07	n/a	n/a	n/a	n/a	10.02M	n/a	10.08K	1.02K	-46.12M	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-0.16	-10.7K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	379.07K	-379.07	n/a	n/a	10.02M	n/a	9.99M	-5.62K	35.08M	1.02M	-46.13M	-42.08K
Debt Repayment	-336K	669K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	26K	-1	-212K	1.76K	1.76K	3.21M	3.21M	6.46M	6.46M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	27.5K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	15.67M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Financial Cash Flow	-443K	7.76M	1.51M	1.76K	1.76K	3.5M	3.21M	6.46K	6.46K	n/a	12.37M	1.12M	11.18M	1.99M	n/a	5.99M	n/a	9.2M	9.88M	2.78M	8.4M	1.32M	157.74K	-40.34K	346.57K	n/a	n/a	15.67K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Net Cash Flow	-1.93M	2.87M	1.31M	-1.67M	-1.67M	7.17M	-8.14M	2.55M	8.13M	-8.57M	7.36M	-4.03M	9.6M	-2.88M	-7.39M	1.74M	-428.47K	4.92M	2.09M	-536.98K	3.51M	-3.54M	325.51K	-4.11M	-5.52M	-8.33M	-4.33M	7.13M	-9.14M	5.2M	-9.18M	28.57M	-4.14M	-51.77M	-7.49M
Free Cash Flow	-1.49M	-4.89M	-4.04M	-3.43K	-3.43K	-9.57M	-4.88M	-3.94K	-3.94K	-8.57M	-5.05M	-5M	-1.56M	-4.87M	-7.42M	-4.23M	-704.17K	-4.27M	-7.74M	-3.46M	-4.91M	-4.77M	228.94K	-4.57M	-5.33M	-8.28M	-4.4M	-8.52M	-9.21M	-4.73M	-9.17M	-6.5M	-5M	-5.7M	-7.48M